Rotavirus genotypes as etiological agents of diarrhoea in general populations of two geographic regions of Brazil by Leite, Marcel et al.
Rev Inst Med Trop São Paulo. 2017;59:e45 Page 1 of 8
ORIGINAL ARTICLE
http://dx.doi.org/10.1590/S1678-9946201759045
(1)Grupo Fleury, Automação, São Paulo, São 
Paulo, Brazil
(2)Universidade Federal de São Paulo, 
Departamento de Medicina, Laboratório 
de Virologia Clínica, Unidade de Doenças 
Infecciosas, São Paulo, São Paulo, Brazil
(3)Instituto Adolfo Lutz, Núcleo de Doenças 
Entéricas, Centro de Virologia, São Paulo, 
São Paulo, Brazil
(4)Universidade Estadual do Centro-Oeste, 
Guarapuava, Paraná, Brazil
Correspondence to: Marcel Leite 
Grupo Fleury, Automação, Av. General 
Waldomiro de Lima, 508, CEP 04344-070, 
São Paulo, SP, Brazil
E-mail: marcelleite83@gmail.com
Received: 27 October 2016
Accepted: 31 March 2017
Rotavirus genotypes as etiological agents of diarrhoea in 
general populations of two geographic regions of Brazil
Marcel Leite1,2, Rita de Cássia Compagnoli Carmona3, Emerson Carraro4, 
Aripuanã Sakurada Aranha Watanabe2, Celso Francisco Hernandes 
Granato1,2
ABSTRACT
Rotavirus is the main global cause of severe childhood diarrhoea among children. In 
2006, Rotarix® (G1P[8]) was introduced into Brazil’s National Immunization Program. The 
vaccine coverage rate was 84.4% in 2009. Evidences of increasing G2P[4] after 2006 opened 
up the discussion about the vaccine effectiveness to non-G1 strains. The aim of this study 
was to identify the circulating rotavirus genotypes in two Brazilian regions during 2009. A 
total of 223 positive samples by immunochromatography and latex agglutination assay from 
the Northeast (Bahia/Pernambuco States) and Southeast (São Paulo/Rio de Janeiro States) 
regions were included in the study. The samples were submitted to genotyping by nested-PCR 
according to VP7(G) and VP4(P) and 175 samples (78.5%) were able to be characterized. 
Considering the characterization of VP7, the G-types detected were G1, G2, and G4 in the 
Northeast, and G2, G3, G5, and G9 in the Southeast. Considering the characterization of 
VP4, the P-types detected were P[4], P[8], and P[6]/P[9] in the Northeast and the Southeast. 
The most frequent mixed types found were G2P[4]/G2P[NT](81.4%), G2P[6](5.2%), G1P[6]
(5.2%) in the Northeast, and G2P[4]/G2P[NT](78.8%), G2P[6](8.2%), G9P[8](4.7%) in the 
Southeast. Among immunized individuals whose age ranged from 0-4 years, the G2P[4]/
G2P[NT] genotype was identified in 91,0% of cases, and among non-immunized individuals 
of the same age, the G2P[4]/G2P[NT] genotype was identified in 85.7% of the cases. In 
accordance with the high level of vaccine coverage, the data suggest that the circulation 
of G2P[4] in these regions had a considerable increase after the introduction of Rotarix®.
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INTRODUCTION
Rotavirus infection is among the top six causes of severe diarrhoea in children, 
having already caused over two million deaths in children under five years of age1. 
It is transmitted via the fecal-oral route or through the consumption of contaminated 
water or food, with a minimum infectious dose of 10 virions2. 
Rotavirus strains can be classified into 8 groups or species (A-H); of these groups 
only A, B, C, and H can infect humans. Recently, two newer groups of rotavirus have 
been proposed (I and J)1,3-5. The molecular characterization of rotavirus is based 
on the gene that corresponds to VP4(P) and VP7(G) proteins. In Brazil, between 
the years of 2006 and 2009, the genotype G2 associated with P[4] or undefined 
VP4 was the most frequent strain. It was present in 49%, 66%, 85%, and 37.5% 
of the samples analyzed each year, respectively. In contrast, genotypes G1 and G3 
associated with P[8] or undefined VP4 have declined in frequency since 20056.
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Rotarix® vaccine, which was included in the Brazilian 
immunization schedule in March 2006, consists of a 
monovalent preparation of the G1P[8] strain. From 2006 
to 2012, the vaccine coverage was 46.5%, 79.8%, 81.2%, 
84.4%, 83.0%, 87.1%, and 86.4%, respectively7. Although 
Rotarix® has proven to be effective against infections by 
non-G1P[8] strains, recent studies have shown an increase 
in frequency and prevalence of the G2P[4] strain in Brazil 
and in Australia, and of the G9P[4] genotype in Mexico6,8-12. 
In this context, the aim of the present study is to describe 
the circulating rotavirus genotypes in two Brazilian regions 
in 2009.
MATERIALS AND METHODS
The 223 samples used in this study were collected during 
the year of 2009 in the Southeast region [States of São 
Paulo (SP - latitude: -23° 32’ 51’’, longitude: -46° 38’ 10’’) 
and Rio de Janeiro (RJ - latitude: -22° 54’ 10’’, longitude: 
-43° 12’ 27’’)] and in the Northeast region [States of Bahia 
(BA - latitude: -12° 58’ 16’’, longitude: -38° 30’ 39’’) 
and Pernambuco (PE - latitude: -08° 03’ 14’’, longitude: 
-34° 52’ 52’’)] of Brazil. These samples come from patients 
of all ages with diarrhoea whose physicians requested 
rotavirus screening in feces. We do not have information 
about the hospitalization of these patients, because samples 
were collected in the outpatient clinic (approved by the 
Ethics Committee - CEP 0771/11). 
Immunochromatographic analyses (Vikia® Rota-Adeno, 
bioMérieux SA, Marcy- I’Étoile, France) were conducted 
in 223 rotavirus positive stool specimens. Viral RNA 
(dsRNA) was extracted in the QIAsymphony (QIAGEN, 
Hilden, Germany) instrument with the QIAsymphony® 
Virus/Bacteria Mini kit (QIAGEN, Hilden, Germany) from 
the supernatant of a suspension containing 10% of feces in 
PBS (10 mmol/L of sodium phosphate and 0.15 mol/L of 
sodium chloride with a pH from 7.2 to 7.4). VP7 and VP4 
genotyping were obtained with two PCR reactions for each 
one of the genes. In the first reaction, BEG/END (VP7) and 
CON3/CON2 (VP4) primer pools were used, whereas in 
the second one, pools 9CON1/9T1-1/9T1-2/9T-3P/9T-4/
FT5/9T-9B (VP7) and CON3/2T-1/3T-1/1T-1/4T-1 (VP4) 
were employed. In the first PCR (RT-PCR), the mixture 
(5 µL dsRNA with 3 µL DMSO) was heated to 93 ºC for 
3 min, and cooled in ice bath for 5 min. Then, 42 µL of the 
following mixture were added [14.2 µL H2O, 16 µL mix 
dNTP (1.25 mM of each dNTP), 5 µL 10 x reaction buffer 
(200 mM Tris-HCl/pH-8.4/500 mM KCl), 5 µL MgCl2 
(50 mM), 1 µL primer pool (20 µM of each primer), 0.4 µL 
Platinum Taq DNA polymerase (Invitrogen, California, 
USA) and 0.4 µL Reverse Transcriptase (Superscript II 
– Invitrogen, California, USA)]. After that, the mixture 
was submitted to the following conditions: 42 ºC/60 min, 
35 cycles (94 ºC/1 min, 42 ºC/2 min, and 72 ºC/1 min), and 
72 ºC/5 min. In the second PCR (semi-nested-PCR), 1 µL 
of the cDNA formed in the RT-PCR was added to 24 µL 
of the mixture [10.3 µL H2O, 8 µL mix dNTP (1.25 mM 
of each dNTP), 2.5 µL 10 x reaction buffer (200 mM 
Tris-HCl/pH-8.4/500 mM KCl), 2.5 µL MgCl2 (50 mM), 
0.5 µL primer pool (20 µM of each primer), 0.2µL Platinum 
Taq DNA polymerase (Invitrogen, California, USA)]. The 
mixture was then submitted to the following conditions: 
25 cycles (94 ºC/1 min, 50 ºC/2 min, and 72 ºC/1 min), 
and 72 ºC/5 min. For all reactions, both negative (H2O) 
and positive (genotyped sample) controls were used. 
PCR products were analyzed by electrophoresis in 1.2% 
GelRed™- Biotium-stained agarose gel (GelRed™ - 
Biotium, California, USA) and genotype identification 
relied on the size of the DNA sequence obtained, using 
bands with previously defined molecular weight sizes as 
a reference [1 Kb plus and 50 pb DNA ladder (Invitrogen, 
California, USA)]13-15. 
RESULTS AND DISCUSSION
Of the 223 samples, 48 were not PCR-positive for 
rotavirus, whereas 175 had the VP7 and/or VP4 genotypes 
identified. There was no significant difference of age, sex, 
place of origin and time of year of collection between the 
48 samples that did not have the presence of viral RNA 
confirmed and the other 175 genotyped samples. The 223 
stool specimens were collected from patients for rotavirus 
testing at the laboratory. The samples were kept refrigerated 
(4-8 ºC) for 4-7 days until their inclusion in this study, when 
they were then frozen at -20 ºC. 
R o t av i r u s  t e s t i n g  i s  p e r f o r m e d  t h r o u g h 
immunochromatography, which detects the presence 
of the VP6 protein. Therefore, sample stability is less 
critical than in genotype analysis, since RNA degrades in 
temperatures above -20 ºC. In 2008, Téllez et al.16 observed 
that the specificity of the Vikia® Rota-Adeno kit was 24.2%, 
lower than the PCR’s. Thus, the absence of RNA in those 
48 samples may be related to sample stability differences 
between the two methods and to the lower specificity of 
immunochromatography. It is also important to note that 
81.3% of the samples were from patients from 0-4 years 
of age and, in this age group, stool collection is more 
complicated and results are drawn from a reduced sample 
volume, making it harder to achieve PCR viral RNA 
stability. The absence of viral RNA may also be due to the 
presence of PCR inhibitors in the feces. 
Of the 175 genotyped samples, 50.9% belonged to 
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women, 45% belonged to men, and 4% did not have 
the gender identified. Regarding the age group, 59.4% 
(-104/175) were children aged from 0-10 years, and of 
those 48 (27.4%; n=48/175) were children from 0-2 years 
(Table 1). The average age observed was of 15.6 years 
old, while the mean age was six years old. Concerning the 
Brazilian state of origin, 52.6% (-92/175) were from the 
Northeast (Pernambuco/Bahia States) and 47.4% (83/175) 
from the Southeast (São Paulo/Rio de Janeiro States). As 
for the time of collection, 58.9% (103/175) were collected 
in the winter, 14.9% (-26/175) in the summer, 13.1% 
(-23/175) in the spring, 10.9% (-19/175) in the autumn, 
and 2.3% (- 4/175) in an unidentified season (Figure 1). 
Rotavirus infection was observed in all age groups, 
but a higher incidence was found in children aged 0-2 
years, confirming the suspicion that this infection is still 
more frequent in this age group of the population, and 
highlighting the need of effective vaccination. Infection in 
adults is mostly associated with the virus being transmitted 
to them by infected children. Therefore, effective childhood 
vaccination may cause an indirect effect of reducing the 
number of infected adults10,12,17. About the distribution 
throughout the year, 69.7% of the genotyped samples 
were concentrated in the colder and drier seasons. In 
this context, the distribution of cases throughout the year 
seems to be similar to that of temperate climate countries, 
where infections happen predominantly in the colder and 
drier months. The present study suggests, however, that 
rotavirus infection in these regions of Brazil is in-between 
the period observed in tropical climate countries where the 
cases are spread throughout the year, what is observed in 
temperate climate countries. Focusing on each one of the 
regions, we noticed that the Northeast region (Pernambuco/
Bahia States) typically presenting tropical weather with 
higher average temperatures and milder temperatures 
in the winter has a higher concentration of cases in the 
winter, whereas the Southeast region (São Paulo/Rio de 
Janeiro States), characterized by lower temperatures in 
the winter had more evenly spread cases throughout the 
year. Therefore, one may state that curiously enough the 
Northeast region demonstrated a profile that is more similar 
to that of temperate climate countries. In agreement with 
this fact, Silva et al.18 observed that rotavirus infection in 
the State of Pernambuco in 2007 and 2008 also happened 
more frequently from May to September (autumn and 
winter). As a whole, it is expected that the general sanitary 
conditions are better in the Southeast region than in the 
Northeast region. 
VP7 genotyping revealed the circulation of G1, G2, 
G3, G4, G5, and G9, though in 6 cases VP7 genotyping 
was not possible. The dominant VP7 genotype was 
G2 (88.0%; -154/175), followed by G1 (4.6%; -8/175) 
(Table 2). VP4 genotyping showed genotypes P[4], P[6], 
P[8], and P[9], though the genotyping of 26 samples 
Table 1 - Classification of samples with VP7 and/or VP4 
genotype identified by age group
Age group Number of samples
0 - 2 years 48
3 - 4 years 25
5 - 10 years 31
11 - 20 years 12
21 - 30 years 19
31 - 40 years 8
41 - 50 years 7
> 50 years 16
No information 9
TOTAL 175
Figure 1 - Classification of samples from the Southeast and Northeast regions of Brazil that were PCR-positive for rotavirus by 
date of collection
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was not possible. The dominant VP4 genotype was P[4] 
(72.0%; n=126/175), followed by P[6] (10.3%; -18/175) 
(Table 3). Additional data are presented in Tables 2 and 3. 
Concerning the combinations of VP7 and VP4, 69.1% 
(-121/175) corresponded to G2P[4], 14.3% (-25/175) to 
G2 with unidentified VP4, 6.9% (-12/175) to G2P[6], and 
13.7% (-24/175) to other strains (G1P[6], G9P[8], P[4] with 
unidentified VP7, G1P[8], P[8] with unidentified VP7, G1 
with unidentified VP4, G1P[4], G3P[9], G4P[6], G5P[8], 
G9 with unidentified VP4, and P[9] with unidentified 
VP7) (Table 4). In the Northeast region, the most common 
rotavirus strains were G2P[4] (72.8%; -67/92), G2 with 
unidentified VP4 (13.0%; -12/92), and G2P[6] (5.4%; 
-5/92), whereas in the Southeast, the most frequently 
found strains were: G2P[4] (65.1%; n=54/83), G2 with 
unidentified VP4 (15.7%; n=13/83), and G2P[6] (8.4%; 
n=7/83) (Table 5). As for the presence of different genotypes 
in the same patient, there were four samples of G2P[4]P[6] 
(Pernambuco, São Paulo, and Bahia States), one of G1P[4]
P[6] (Bahia State), one of G2/G9 with unidentified VP4 
(SP), and one of P[8]/P[9] with unidentified VP7 (Bahia 
State). 
A pool of G1-, G2-, G3-, G4-, G5- and G9-specific 
primers was used for the VP7 genotyping. Of the 175 
genotyped samples, six did not have the VP7 type identified. 
There was gene amplification in one of those samples in the 
first PCR, but not in the second one, which indicates that 
the genotype is not among those chosen as the focus of this 
study, characterizing it as emerging or of low circulation, 
since this study focuses on the top circulating genotypes 
in the Brazilian population9,19. The other five cases had no 
VP7 gene amplification in the first or second PCR, with the 
presence of the virus beingconfirmed by VP4 genotyping. 
Table 2 - Classification of samples confirmed as rotavirus-
positive by VP7 genotype








Table 3 - Classification of samples confirmed as rotavirus-
positive by VP4 genotype
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In the studied population, VP7 genotyping revealed the 
circulation of all investigated genotypes (G1, G2, G3, G4, 
G5 and G9), with G2 and G1 as the most frequent ones. On 
a global scale, Santos and Hoshino20 noticed that from 1989 
to 2004, the dominant VP7 genotype was G1. In Brazil, 
Gurgel et al.9 noticed that before the inclusion of Rotarix® 
in the immunization schedule, from 1986 to 2006, the most 
frequent VP7 genotype was G1, representing 44% of the 
total, followed by G9 with 19% and G2 with 17%. Still in 
Brazil, Leite et al.19 observed that from 1982 to 2005 G1 
was the most common VP7 genotype, representing 43% 
of the cases and G2 representing 9%, whereas from 2006 
to 2007 (approximately one year after the implementation 
of Rotarix®) G1 had its frequency reduced to only 3% of 
the cases and G2 became the most frequent genotype, 
representing 74% of the cases, followed by G9 with 11%. 
Focusing on the G2 frequency only, Leite et al.19 observed 
that from 1982 to 1995 this genotype was identified in 26% 
of the cases; from 1996 to 2005, this rate dropped to 2%, and 
from 2006 to 2007, it increased to 74%. One could assume 
that the VP7 profile observed in this study is similar to the 
one seen after the implementation of Rotarix®. 
The VP4 genotyping used the same methodology as the 
VP7 genotyping, with the primer pool of the second PCR 
corresponding to P[4], P[6], P[8], and P[9] genotypes. Of 
the 175 genotyped samples, 26 had unidentified VP4 and 
turned out negative in the first and second PCR rounds, 
being confirmed as rotavirus-positive by VP7 identification. 
The VP4 genotyping revealed the circulation of four of the 
studied genotypes (P[4], P[6], P[8], and P[9]), with P[4] 
as the most common one (70%). Santos and Hoshino20 
noted that from 1989 to 2004 the two most common VP4 
genotypes in the world were P[8] and P[4]. Focusing 
on the period between 1986 and 2006 in Brazil, Gurgel 
et al.9 stated that before the introduction of Rotarix® in 
the official immunization schedule, P[8], P[4], and P[6] 
had frequency rates of 75%, 10% and 6%, respectively. 
In a different study, Leite et al.19 analyzed the Brazilian 
population from 1982 to 2007 and named the one-year 
period from 2006 to 2007 as the post-Rotarix® period. 
From 1982 to 2005, P[8] was present in approximately 
70% of the cases and P[4] in 9%. From 2006 to 2007, in 
contrast, P[4] was identified in approximately 70% of the 
cases and P[8] in about 15%. Considering the descriptions 
in the literature, one could say that the prevalent profile 
observed in this study for the VP4 genotypes resembles 
that of the post-Rotarix® period.
Of the total genotyped samples, 3% and 15% were PCR 
negative for VP7 and VP4, respectively. This may be related 
to genetic drifts, genomic rearrangements (shifts), or genetic 
reassortments that take place in the primer binding site.21-29. 
As for the historically usual VP7-VP4 combinations 
(G1P[8], G2P[4], G3P[8] and G4P[8]), there were no 
cases of G3P[8] and G4P[8], and only two of G1P[8]. 
G2P[4], on the other hand, it was observed in 69% of the 
samples. G9P[8], which was recently found with a higher 
frequency and classified as a usual strain, was reported in 
only 2.3% of the samples. Only one case of G5P[8] was 
found. Literature data indicate that G1P[8] was the most 
prevalent strain in the world from 1989 to 2004. In Brazil, 
G1P[8], G9P[8], G2P[4], G3P[8], G4P[8] and G5P[8] were, 
in ascending order, the most common strains from 1982 to 
2005. After 2006, the year in which Rotarix® was included 
in the Brazilian immunization schedule, there was a change 
in the circulation of strains. G2P[4] took the lead as the 
most frequent type, while G1P[8] ranked third.9,11,19,20,30 
Approximately 5% of rotavirus cases are caused by 
uncommon combinations of VP7 and VP4. In this study, 
we found the following uncommon combinations: G1P[4], 
G1P[6] G2P[6], G3P[9], and G4P[6], which altogether 
accounted for 10% of the cases (n=18).
Literature data suggest that the infection by two or more 
genotypes of rotavirus (mixed infection) has a frequency 
rate of 15% in South American countries. It is believed that 
those infections occur more often in regions where there is 
greater diversity and circulation of uncommon strains20,31. 
In this study, seven cases of mixed infections (4%) were 
found. Of those, four samples had P[4]/P[6] associated with 
G2, one had P[4]/P[6] associated with G1, one had G2/G9 
associated with unidentified VP4, and one sample had 
P[8]/P[9] associated with unidentified VP7. 
Comparing the regions of study (Southeast and 
Northeast) by genotype, we see that the three most frequent 
ones (G2P[4], G2 with unidentified VP4, and G2P[6]) have 
similar rates in both regions, representing approximately 
87% of the samples. Among the historically usual strains, 
G1P[8] was found only in two cases in the Northeast 
region, G2P[4] was the dominant type in both regions, 
and G9P[8] and G5P[8] were found only in the Southeast 
region in approximately 5% and 1% of the samples, 
respectively. As for the uncommon VP7-VP4 combinations, 
G1P[6], G1P[4], G4P[6], and G2P[6] were circulating in 
approximately 12% of the samples from the Northeast, 
whereas G3P[9] and G2P[6] were seen in about 9% of the 
samples from the Southeast. Regarding cases of mixed 
infection, there was a 5% rate in the Northeast samples 
against 2% in the Southeast ones. In the Northeast group, 
there were three samples with G2-associated P[4]/P[6], 
one with G1-associated P[4]/P[6], and one with P[8]/P[9] 
associated with an unidentified VP7. In the Southeast 
group, there was one sample with G2/G9 associated with 
unidentified VP4 and one with G2-associated P[4]/P[6]. 
Leite et al.
Rev Inst Med Trop São Paulo. 2017;59:e45Page 6 of 8
Official data from the Brazilian Ministry of Health 
reveal that in 2009 the Rotarix® vaccine coverage in the 
states of Pernambuco, Bahia, Rio de Janeiro, and São 
Paulo was 88.6%, 78.5%, 80.5%, and 89.1%, respectively7. 
Corroborating literature findings (Table 6) for the 
post-Rotarix® period, this study found an approximate 
predominance of 83% of G2 associated with P4 or 
with an unidentified VP4, an absence of G3P[8] and 
G4P[8], and only two cases of G1P[8] (1% of the studied 
samples), which shows a significant increase in the 
G2P[4] predominance. Selective pressure exerted by the 
vaccination has eventually led the unvaccinated population 
to be affected by the strains that are predominant among 
vaccinated individuals.
CONCLUSION
Of the VP7 genotypes found, only G2 was circulating 
in both of the regions studied. G1 and G4 were circulating 
only in the Northeast region (Bahia and Pernambuco 
States) whereas G3, G5, and G9 were circulating only in 
the Southeast region (São Paulo and Rio de Janeiro States). 
The VP4 genotypes that were found (P[4], P[6], P[8] and 
P[9]), on the other hand, were all circulating in both regions. 
G2P[4] proved to be the most common combination in 
both regions (Bahia and Pernambuco – 72.8%; São Paulo 
and Rio de Janeiro – 65.1%). The G2P[4] predominance 
was seen in a population with a reasonable coverage of 
Rotarix®, but further studies are needed to understand the 
reasons that may have led to this increase of genotype two 
and to define whether or not the vaccine formulation should 
be modified. According to our data, multivalent vaccines 
might have to be proposed in order to be useful to different 
regions of the country. 
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